Waters ACQUITY Premier Ultra-High-Performance Bio-Inert Liquid Chromatography System (Rental)

Overview

The Waters ACQUITY Premier Ultra-High-Performance Bio-Inert Liquid Chromatography System is engineered for laboratories requiring maximum sensitivity, reproducibility, and robustness in LC and LC-MS analyses—particularly for metal-sensitive, low-abundance, or highly reactive biomolecules. Unlike conventional UPLC systems, the ACQUITY Premier integrates MaxPeak High-Performance Surface (HPS) technology across its entire fluidic path—including pump heads, injector valves, tubing, and detector flow cells—to minimize analyte adsorption, surface-induced degradation, and carryover. This bio-inert architecture operates on the principle of surface passivation via a proprietary hybrid organic-inorganic coating, effectively eliminating active metal sites (e.g., stainless steel chromium oxide defects) that catalyze deamidation, oxidation, or chelation of peptides, oligonucleotides, ADCs, and metalloproteins. As a result, the system delivers superior peak shape symmetry, enhanced signal-to-noise ratios, and quantifiable improvements in method ruggedness—especially under extended gradient runs or low-pH mobile phase conditions.

Key Features

• MaxPeak HPS technology applied to all wetted surfaces: pump manifolds, needle seats, sample loops, column ovens, and detector cells
• Maximum operating pressure: 15,000 psi (1034 bar), enabling sub-2-µm particle column utilization with high-resolution separations
• Flow rate range: 0.001–2.000 mL/min with ≤0.07% RSD precision at 0.01 mL/min (per ASTM D6982)
• pH compatibility: 1.0–12.5, supporting both acidic peptide mapping and basic small-molecule applications without hardware corrosion risk
• Sample injection options: Flow-through needle (FTN) for ultra-low carryover (<0.002%) and fixed-loop configuration for high-precision direct injection
• Column manager with eCord-enabled tracking: records thermal history, pressure exposure, and cycle count per column; supports up to six columns (max 150 mm length, 4.6 mm ID)
• Active pre-heating of solvents and column oven (4–40 °C) with ±0.1 °C stability—critical for retention time reproducibility in regulated environments

Sample Compatibility & Compliance

The ACQUITY Premier is validated for use with biologics, monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), oligonucleotides, glycans, and metal-coordinating small molecules (e.g., platinum-based chemotherapeutics). Its inert fluidic pathway eliminates the need for routine passivation protocols—reducing method qualification time and supporting ICH Q5E comparability studies. The system meets key regulatory expectations for GxP workflows: Empower 3 software complies with FDA 21 CFR Part 11 (audit trail, electronic signatures, role-based access control); UNIFI supports raw data integrity per ALCOA+ principles; MassLynx enables secure instrument control in GLP-compliant mass spectrometry integration. All hardware components conform to ISO 9001 manufacturing standards and CE/UL safety directives.

Software & Data Management

• Empower 3 Chromatography Data System (CDS): Single-system license for five concurrent users; supports automated system suitability testing, peak purity assessment, and multi-point calibration per USP <621>
• UNIFI Scientific Information System: Centralized platform for method lifecycle management, spectral library searching, and cross-instrument data harmonization—designed for QC/QA labs operating multiple LC and LC-MS platforms
• MassLynx MS Software: Full control of Waters Xevo, Vion, and SYNAPT mass spectrometers; includes TargetLynx quantitative processing and PLGS protein identification workflows
• Data archival: Raw .raw files stored in vendor-neutral format; metadata embedded per ASTM E2524 standard for long-term traceability

Applications

This system is routinely deployed in biopharmaceutical development labs for charge variant analysis (CEX), hydrophobic interaction chromatography (HIC), and intact mass analysis of mAbs. It is also specified in analytical method transfers for biosimilar characterization, where column-to-column and lab-to-lab reproducibility are critical. In academic proteomics cores, the ACQUITY Premier enables reliable bottom-up and top-down workflows for post-translational modification mapping—particularly for phosphopeptides and sialylated glycopeptides prone to on-surface loss. Environmental and food safety labs leverage its pH resilience for simultaneous detection of mycotoxins and heavy-metal complexes in complex matrices such as infant formula or herbal extracts.

FAQ

Is the ACQUITY Premier compatible with existing Waters UPLC methods?
Yes—backward compatibility with ACQUITY UPLC PLUS methods is maintained through identical gradient delay volumes, dwell volume calibration routines, and Empower 3 method import functionality.
Can MaxPeak HPS surfaces be cleaned with strong acids or bases?
Yes—the coating is stable across pH 1–12.5; however, prolonged exposure (>30 min) to >1 M HCl or NaOH is not recommended per Waters Technical Note TN1042.
What rental terms are available for GMP-regulated environments?
Short-term (1–6 months), rent-to-own (24–36 months with title transfer), and lease-to-own (with full ownership at term end) options include IQ/OQ documentation support and annual preventive maintenance contracts.
Does the system support 21 CFR Part 11 compliance out-of-the-box?
Empower 3 is pre-configured for Part 11 compliance; validation packages—including risk assessments, URS, and test scripts—are provided upon request for audit-ready deployment.
How is column lifetime tracked and reported?
eCord-enabled columns store usage logs (temperature cycles, pressure spikes, injection count) directly on the RFID tag; Empower 3 auto-imports this data into the Column Log report for trending and replacement alerts.